Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial

Journal of the American Medical Association

Volumn 280, Issue 21, 1998, Pages 1837-1842

  Rowbotham, Michael ^a   Harden, Norman ^b   Stacey, Brett ^c   Bernstein, Paula ^d   Magnus Miller, Leslie ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; NARCOTIC AGENT; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; ATAXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HERPES ZOSTER; HUMAN; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SOMNOLENCE; VERTIGO;

EID: 0032477305     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.21.1837     Document Type: Article

References (32)

1. Watson CPN, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15:510-526.
2. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N Engl J Med. 1996;335:32-42.
3. Herne K, Cirelli R, Lee P, Tyring SK. Antiviral therapy of acute herpes zoster in older patients. Drugs Aging. 1996;8:97-112.
4. Johnson RW. Aspects of postherpetic neuralgia: can we zap Z-aP? Pain Rev. 1996;3:117-135.
5. Watson CPN. The treatment of postherpetic neuralgia. Neurology. 1995;45(suppl 8):S58-S60.
6. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47:305-312.
7. Max MB, Schafer SC, Culnane BSN, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988;38:1427-1432.
8. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol. 1994;35:S50-S53.
9. Takeda Y, Kobayashi H, Suzuki K, Sei Y, Nishio K, Ishizaki H. Analgesic effects of clomipramine (Anafranil) on postherpetic neuralgia. Skin Res. 1988;30:33-36.
10. Watson CPN, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32: 671-673.
11. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain. 1985;23:387-394.
12. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain. 1992;48:29-36.
13. Bowsher D. Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom. Manage. 1996;12:290-299.
14. Göbel H, Stadler T. Treatment of post-herpes zoster pain with tramadol: results of an open pilot study versus clomipramine with or without levomepromazine. Drugs. 1997;53(suppl 2):34-39.
15. Gerson GR, Jones RB, Luscombe DK. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia. Postgrad Med J. 1977;53(suppl 4):104-109.
16. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997;73: 123-139.
17. Volmink J, Lancaster T, Gray S, Silagy C. Treatments for postherpetic neuralgia - a systematic review of randomized controlled trials. Fam Pract. 1996;13:84-91.
18. Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs. 1993;46:409-427.
19. Bruni J, Saunders M, Anhut H, Sauermann W. Efficacy and safety of gabapentin (Neurontin): a multicenter, placebo-controlled, double-blind study. Neurology. 1991;41(suppl 1):330-331.
20. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet. 1990;335:1114-1117.
21. US Gabapentin Study Group. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology. 1993;43:2292-2298.
22. Gillin S, Sorkin LS. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug. Anesth Analg. 1998;86:111-116.
23. Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth. 1997;22:249-256.
24. Singh L, Field MJ, Ferris P, et al. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology. 1996; 127:1-9.
25. Xiao W-H, Bennett GJ. Gabapentin has an antinociceptive effect mediated via a spinal site of action in a rat model of painful peripheral neuropathy. Pain. 1996;2:267-273.
26. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage. 1995;10:265-266.
27. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12:56-58.
28. Stacey BR, Owen GT, Sinclair JD, Glick RM, Tipton KD. Gabapentin for neuropathic pain states: a case series report [Abstract]. Reg Anesth. 1996; 21:S65.
29. Rosenberg JM, Harrell C, Ristic H, Werner R, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain. 1997;13:251-255.
30. Attal N, Parker F, Brasseur L, Chauvin M, Bouhassira D. Efficacy of gabapentin on neuropathic pain: a pilot study. In: Program and abstracts of the 16th Annual Scientific Meeting of the American Pain Society; October 23-26, 1997; New Orleans, La. Abstract 653.
31. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276: 637-639.
32. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311: 1047-1052.